HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Candidozyma auris is a rapidly emerging fungal pathogen whose drug-resistant profile poses a formidable challenge to antifungal treatment. Echinocandins are the recommended first-line therapy for invasive C. auris infections, but resistance to this drug class is on the rise. Here we show that, beyond resistance, C. auris can readily acquire genetically encoded echinocandin tolerance, a phenotype of slow but sustained growth and increased survival at concentrations above the minimum inhibitory concentration (MIC) that reflects incomplete maximal inhibition and a reduced Hill coefficient without an increase in MIC. Tolerance was therefore undetectable by standard clinical susceptibility testing, yet it significantly reduced treatment efficacy in an immunocompromised murine model of systemic infection. Genetic dissection revealed that tolerance arises through disruption of the high-osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathway through the loss of function of Ssk1, Ssk2, Pbs2 or Hog1, or specific substitutions in Nik1. The disruption of the HOG pathway did not confer fitness or virulence defects in C. auris, and in Candida albicans and Nakaseomyces glabratus, it did not confer tolerance, suggesting a unique non-essential rewiring of this pathway in C. auris. Proteomic and cell-wall analyses linked tolerance to altered cell-wall remodelling during echinocandin exposure. Evolutionary modelling and deep sequencing of FKS1 hotspots in experimentally evolved populations showed that tolerance increases the rate at which resistance-conferring FKS1 hotspot substitutions emerge. Putative high-impact mutations in HOG pathway effectors in clinical isolates suggest that this phenotype occurs in patients, where it might reduce treatment efficacy or facilitate resistance emergence. This work therefore identifies HOG-mediated acquired tolerance as a hidden clinically relevant direct and indirect determinant of echinocandin treatment failure.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.11.765954
Primary Topic
Antifungal resistance and susceptibility
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Toni Gabaldón, Ian Leaves, Celia Lobo Romero, Neil A. R. Gow et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Antifungal resistance and susceptibility
preprint

HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Toni Gabaldón, Ian Leaves, Celia Lobo Romero, Neil A. R. Gow, Dhara Malavia, Hans Carolus, Christian R. Landry, Judith G. Berman, Alvis Zvirgzdins, Hugh Gifford, Alicia Pageau, Alons Lends, Stef Jacobs, Austin Mottola, Louise A. Walker, Carol A. Munro, Dimitrios Sofras, Alexandre K. Dubé, Jan Jacques Michiels, Bram Van den Bergh, Markus Ralser, Vladislav V. Biriukov, Rhys A. Farrer, Pieter van den Berg, Patrick Van Dijck, Ziyue Wang, Giorgio Boccarella, Anitra Zīle
preprint en

Abstract

Candidozyma auris is a rapidly emerging fungal pathogen whose drug-resistant profile poses a formidable challenge to antifungal treatment. Echinocandins are the recommended first-line therapy for invasive C. auris infections, but resistance to this drug class is on the rise. Here we show that, beyond resistance, C. auris can readily acquire genetically encoded echinocandin tolerance, a phenotype of slow but sustained growth and increased survival at concentrations above the minimum inhibitory concentration (MIC) that reflects incomplete maximal inhibition and a reduced Hill coefficient without an increase in MIC. Tolerance was therefore undetectable by standard clinical susceptibility testing, yet it significantly reduced treatment efficacy in an immunocompromised murine model of systemic infection. Genetic dissection revealed that tolerance arises through disruption of the high-osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathway through the loss of function of Ssk1, Ssk2, Pbs2 or Hog1, or specific substitutions in Nik1. The disruption of the HOG pathway did not confer fitness or virulence defects in C. auris, and in Candida albicans and Nakaseomyces glabratus, it did not confer tolerance, suggesting a unique non-essential rewiring of this pathway in C. auris. Proteomic and cell-wall analyses linked tolerance to altered cell-wall remodelling during echinocandin exposure. Evolutionary modelling and deep sequencing of FKS1 hotspots in experimentally evolved populations showed that tolerance increases the rate at which resistance-conferring FKS1 hotspot substitutions emerge. Putative high-impact mutations in HOG pathway effectors in clinical isolates suggest that this phenotype occurs in patients, where it might reduce treatment efficacy or facilitate resistance emergence. This work therefore identifies HOG-mediated acquired tolerance as a hidden clinically relevant direct and indirect determinant of echinocandin treatment failure.

bioRxiv (Cold Spring Harbor Laboratory)
Tel Aviv University (IL), University of Aberdeen (GB), University of Exeter (GB), Latvijas Organiskās Sintēzes Institūts (LV), Institute for Research in Biomedicine (ES), Université Laval (CA), Charité - Universitätsmedizin Berlin (DE), Universitat Politècnica de Catalunya (ES), KU Leuven (BE)
Genome Canada, Wellcome Trust, Joint Programming Initiative on Antimicrobial Resistance, National Institute for Health and Care Research, Department of Health and Social Care, European Commission, Fonds Wetenschappelijk Onderzoek, KU Leuven, Ministerio de Ciencia e Innovación, Latvijas Zinātnes Padome, Vlaamse regering, Medical Research Council Centre for Medical Mycology, Berlin University Alliance, HORIZON EUROPE Framework Programme, Medical Research Council, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación
Good health and well-being
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon